Average Price Target: $0.00
▼ -100.00% Downside Potential
This price target is based on 2 analysts offering 12 month price targets for TransEnterix in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $4.08.
The current consensus among 2 investment analysts is to hold stock in TransEnterix. This rating has held steady since June 2019, when it changed from a Buy consensus rating.
TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.